Grant

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)

CountryUnited States
Deadline2028-01-07 (411 days left)
Published2024-11-21
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity PAR-25-286. CFDA: 93.242

The buyer, the value, the full description and the link to the official notice are available with a free account.